Peptides & evidence
Compounded Peptides and the FDA: What Approval Means
FDA-approved, compounded and research use only are very different labels. Here is what each means for peptides and how to judge a product.
- FDA approval means the agency found a drug's benefits outweigh its risks for a specific use.
- Compounded drugs, including compounded peptides, are not FDA-approved.
- A research use only label means the product was not made or approved for people.
- FDA has flagged safety concerns about several peptide ingredients used in compounding.
- Ask where a product comes from, who made it and what is known about it in people.
You saw an ad for a peptide that promises faster recovery, better sleep or a leaner build. The fine print says "made in a US pharmacy" or "research grade," and the price looks reasonable. Those labels sound reassuring, but they mean very different things, and none of them means the same as FDA-approved.
What FDA-Approved Means
When the FDA approves a drug, it means the agency has determined that the drug's benefits outweigh its risks for its intended use, according to the FDA's page Is It Really 'FDA Approved'? Approval covers a specific product, made a specific way, for a specific use.
The same FDA page makes two other points worth knowing. Compounded drugs are not FDA-approved, and the FDA does not review them before they are sold to check their safety, effectiveness or quality. And when a company or product is registered or listed with the FDA, that does not mean the FDA approved it.
What Compounding Is
Compounding is when a pharmacist or doctor prepares a drug instead of it coming from a drug maker's factory line. It can help a patient who cannot use an approved medicine. Federal law sets out two main paths, named after sections of the law, and the FDA's compounding questions and answers describe both.
- 503A pharmacies. These are traditional compounding pharmacies, run by a licensed pharmacist in a state-licensed pharmacy, or a doctor. They are not held to the same manufacturing quality rules (called CGMP) that drug makers follow.
- 503B outsourcing facilities. These are a category created in 2013. The FDA inspects them on a risk-based schedule, and they must follow the higher CGMP quality standards.
Neither path makes a compounded drug FDA-approved. The FDA also notes that poor compounding practices can lead to serious quality problems, such as contamination or a drug with too much or too little active ingredient.
Research Use Only and Not for Humans
Many peptides sold online carry labels like "for research use only" or "not for human consumption." These products are not approved medicines, and they were not made or tested for use in people.
The FDA has sent warning letters to online peptide sellers that used these labels. In them, the FDA has said that, despite the research-only wording, the way the products were marketed showed they were intended as drugs for people, which made them unapproved new drugs.
FDA Concerns About Peptide Ingredients
Compounders cannot use just any raw ingredient. The FDA reviews ingredients that have been nominated for use in compounding. On its page about bulk drug substances that may present significant safety risks, it lists ingredients in "category 2," where it has identified potential significant safety risks.
As of that page's April 22, 2026 update, the peptides listed in category 2 are growth hormone releasing peptide-2 (GHRP-2), growth hormone releasing peptide-6 (GHRP-6), ipamorelin acetate and kisspeptin-10. For several peptides, the FDA's stated concerns include a possible risk of immune reactions, linked to how peptides can clump together and to impurities from making them.
The same page lists other peptides, including BPC-157, TB-500, CJC-1295, AOD-9604 and melanotan II, as previously in category 2 but withdrawn because the people who nominated them withdrew their nominations. The page does not say the FDA found them safe. For BPC-157, the FDA wrote that it had little or no safety information for the proposed routes of use.
In July 2026, the FDA's Pharmacy Compounding Advisory Committee met to discuss whether several peptides, including BPC-157, KPV, TB-500, MOTs-C, emideltide, Semax and Epitalon, should be added to the list of ingredients allowed for 503A compounding for specific uses. An advisory committee gives advice. The FDA makes the decision, and rules can change, so check the FDA's pages for the current status.
MythIf a peptide was taken off the FDA's category 2 list, the FDA has cleared it.
FactThe FDA's page says the peptides moved off category 2 in its withdrawn list were withdrawn by the people who nominated them. That is not an FDA finding of safety or approval.
MythA peptide from a US compounding pharmacy is FDA-approved.
FactCompounded drugs are not FDA-approved, and the FDA does not check their safety, effectiveness or quality before they are sold.
How to Evaluate a Product
These terms come up again and again. Here is what each means and a question to ask.
| Term | What it means | What to ask |
|---|---|---|
| FDA-approved | The FDA found the benefits outweigh the risks for a specific use. | Approved for what use? Is that my use? |
| Compounded | Prepared by a pharmacy or outsourcing facility; not FDA-approved. | Which pharmacy made it, and where is it licensed? |
| 503A pharmacy | A state-licensed compounding pharmacy, not held to CGMP rules. | Is the pharmacy licensed in my state? |
| 503B outsourcing facility | A compounder the FDA inspects that must meet CGMP standards. | Is it registered with the FDA as an outsourcing facility? |
| FDA registered | The company is on file with the FDA. It is not approval. | Is the product itself approved, or only the company registered? |
| Category 2 | An ingredient where the FDA has identified potential significant safety risks for compounding. | Is this ingredient on the FDA's category 2 list right now? |
| Research use only | Not made or approved for use in people. | Why is a product for people labeled this way? |
Red Flags to Watch For
- A "research use only" label on a product sold with dosing guides or mixing water for injection.
- No prescription, health history or clinician involved.
- No named pharmacy, or a pharmacy you cannot look up.
- "FDA registered" used as if it meant FDA-approved.
- Promises of guaranteed results or no side effects.
- Pressure to buy large amounts or sign up for auto-shipments.
Next Steps
If you are looking at a peptide and want a careful second opinion, learn about our peptide consultation. Bring the product name, the seller and any labels. For more questions to ask, read peptide therapy claims: what to ask about evidence and safety, or book a visit.
Sources
This guide is general information, not medical advice for your situation. Medical disclaimer
